Matinas BioPharma Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTNB research report →
About the company
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts.
- CEO
- Jerome D. Jabbour
- IPO
- 2014
- Employees
- 3
- HQ
- Bedminster, NJ, US
Price Chart
- Market Cap
- $3.58M
- P/E
- -0.32
- P/S
- 0.00
- P/B
- 1.37
- EV/EBITDA
- -0.24
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -204.27%
- ROIC
- -155.55%
- Revenue
- $0 · 0.00%
- Net Income
- $-10,345,000 · 57.34%
- EPS
- $-2.00 · 59.84%
- Op Income
- $-6,960,000
- FCF YoY
- 55.86%
- 52W High
- $3.09
- 52W Low
- $0.48
- 50D MA
- $0.68
- 200D MA
- $0.88
- Beta
- 1.71
- Avg Volume
- 155.91K
Get TickerSpark's AI analysis on MTNB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 30, 25 | NEUGEBOREN EDWARD | other | 11,600 |
| Apr 30, 25 | Smith Robin L | other | 11,600 |
| Apr 30, 25 | D An Evelyn | other | 11,600 |
| Apr 30, 25 | Jabbour Jerome D | other | 70,100 |
| Apr 30, 25 | Murphy Keith | other | 11,600 |
| Feb 13, 25 | STERN ADAM K | other | 0 |
| Feb 13, 25 | STERN ADAM K | other | 2,399,318 |
| Feb 13, 25 | STERN ADAM K | other | 4,798,636 |
| Apr 8, 25 | Sanitam Partners LLC | buy | 2,399,318 |
| Apr 8, 25 | Sanitam Partners LLC | buy | 703 |
Our MTNB coverage
Recent articles, reports, and earnings notes.
No research on MTNB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MTNB report →Similar companies
Peers in the same neighborhood.